Tempur-Pedic Reports Record Third Quarter 2010 Sales and Earnings

Oct 19, 2010, 16:05 ET from Tempur-Pedic International Inc.

LEXINGTON, Ky., Oct. 19 /PRNewswire-FirstCall/ --

  • Reports Sales Up 32% and EPS Up 82% at $0.62
  • Gross Margin Up 340 Basis Points to 51.0% and Operating Margin Up 400 Basis Points to 23.0%
  • Raises Financial Guidance for 2010
  • Expands Share Repurchase Authorization to $150 Million

Tempur-Pedic International Inc. (NYSE: TPX), the leading manufacturer, marketer and distributor of premium mattresses and pillows worldwide, today announced financial results for the third quarter ended September 30, 2010. The Company also increased full year 2010 financial guidance and expanded its share repurchase authorization.

Financial Summary

  • Earnings per share (EPS) were $0.62 per diluted share in the third quarter of 2010 as compared to $0.34 per diluted share in the third quarter of 2009. The Company reported net income of $44.2 million for the third quarter of 2010 as compared to $25.7 million in the third quarter of 2009.
  • Net sales increased 32% to $295.8 million in the third quarter of 2010 from $224.1 million in the third quarter of 2009. On a constant currency basis, net sales increased 34%. Net sales in the North American segment increased 47%, while International segment net sales increased 4%. On a constant currency basis, International segment net sales increased 11%.  
  • Mattress sales increased 33% globally. Mattress sales increased 46% in the North American segment and 3% in the International segment. On a constant currency basis, International mattress sales increased 10%. Pillow sales increased 20% globally. Pillow sales increased 39% in North America and 3% internationally. On a constant currency basis, International pillow sales increased 7%. Other product sales increased 37% globally. Other product sales increased 52% in North America and 8% internationally. On a constant currency basis, International other product sales increased 15%.
  • Gross profit margin was 51.0% as compared to 47.6% in the third quarter of 2009. The gross profit margin increased as a result of fixed cost leverage, improved efficiencies in manufacturing, and favorable product and channel mix, partially offset by higher commodity costs and geographic mix.
  • Operating profit margin was 23.0% as compared to 19.0% in the third quarter of 2009. The increase was driven by gross profit margin and operating expense leverage.
  • The Company generated $71.9 million of operating cash flow as compared to $55.0 million in the third quarter of 2009.  

Chief Executive Officer Mark Sarvary commented, "We are pleased with the market share gains and the sales and earnings growth we have achieved in the third quarter. Throughout 2010 we have grown sales and profit while improving our competitive position - strengthening our product line, improving the effectiveness of our marketing and increasing our margins. We continue to project considerable potential for growth for Tempur-Pedic over the coming years, and over the coming quarters we will invest to capitalize on this opportunity."

Share Repurchase Program

During the third quarter of 2010, the Company purchased 1.8 million shares of its common stock at an average price of $27.57 for a total cost of $50.0 million. During the first three quarters of 2010, the Company purchased 8.5 million shares of its common stock at an average price of $29.41 for a total cost of $250.0 million.

The Company announced that the Board of Directors had expanded the Company's existing share repurchase program by $50.0 million for a total authorization of up to $150.0 million. Reflecting share repurchases made during the third quarter, the Company currently has $100.0 million remaining under this authorization. Stock repurchases may be made through open market transactions, negotiated purchases or otherwise, at times and in such amounts as management and a committee of the Board deem appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, financing and regulatory requirements and other market conditions. Repurchases may also be made under a Rule 10b5-1 plan, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so under insider trading laws. The share repurchase program may be limited, suspended or terminated at any time without prior notice.

Financial Guidance

The Company increased its full year 2010 guidance for net sales and earnings per share. It currently expects net sales for 2010 to range from $1.095 billion to $1.115 billion. It currently expects EPS for 2010 to range from $2.05 to $2.10 per diluted share. The Company noted its expectations are based on information available at the time of this release, and are subject to changing conditions, many of which are outside the Company's control. The Company noted its EPS guidance does not assume any benefit from a potential additional reduction in shares outstanding related to its repurchase authorization.

Conference Call Information

Tempur-Pedic International will host a live conference call to discuss financial results today, October 19, 2010 at 5:00 p.m. Eastern Time. The dial-in number for the conference call is 888-293-6960. The dial-in number for international callers is 719-325-2289. The call is also being webcast and can be accessed on the investor relations section of the Company's website, http://www.tempurpedic.com. After the conference call, a webcast replay will remain available on the investor relations section of the Company's website for 30 days.

Forward-looking Statements

This release contains "forward-looking statements," within the meaning of federal securities laws, which include information concerning one or more of the Company's plans, objectives, goals, strategies, and other information that is not historical information. When used in this release, the words "estimates," "expects," "anticipates," "projects," "plans," "intends," "believes," and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements include, without limitation, statements relating to the potential to significantly grow sales and earnings over the coming years, investment in initiatives that will drive growth over the long term, the share repurchase authorization, and the Company's expectations for net sales and earnings per share for 2010. All forward looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct.

There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the Company's control, could cause actual results to differ materially from those expressed as forward-looking statements. These risk factors include general economic, financial  and industry conditions, particularly in the retail sector, as well as consumer confidence and the availability of consumer financing; uncertainties arising from global events; the effects of changes in foreign exchange rates on the Company's reported earnings; consumer acceptance of the Company's products; industry competition; the efficiency and effectiveness of the Company's advertising campaigns and other marketing programs; the Company's ability to increase sales productivity within existing retail accounts and to further penetrate the Company's retail channel, including the timing of opening or expanding within large retail accounts; the Company's ability to address issues in certain underperforming international markets; the Company's ability to continuously improve and expand its product line, maintain efficient, timely and cost-effective production and delivery of its products, and manage its growth; changes in tax rates, including the ability to utilize tax loss carry forwards; and rising commodity costs. Additional information concerning these and other risks and uncertainties are discussed in the Company's filings with the Securities and Exchange Commission, including without limitation the Company's annual report on Form 10-K under the headings "Special Note Regarding Forward-Looking Statements" and "Risk Factors." Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements for any reason, including to reflect events or circumstances after the date on which such statements are made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

About the Company

Tempur-Pedic International Inc. (NYSE: TPX) manufactures and distributes mattresses and pillows made from its proprietary TEMPUR(R) pressure-relieving material. It is the worldwide leader in premium and specialty sleep. The Company is focused on developing, manufacturing and marketing advanced sleep surfaces that help improve the quality of life for people around the world. The Company's products are currently sold in over 80 countries under the TEMPUR(R) and Tempur-Pedic(R) brand names. World headquarters for Tempur-Pedic International is in Lexington, KY. For more information, visit http://www.tempurpedic.com or call 800-805-3635.

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(In thousands, except per common share amounts)

Three Months Ended

Nine Months Ended

September 30,

September 30,

2010

2009

Chg %

2010

2009

Chg %

Net sales

$

295,785

$

224,082

32.0%

$

812,718

$

586,362

38.6%

Cost of sales

145,031

117,373

409,114

311,461

Gross profit

150,754

106,709

41.3%

403,604

274,901

46.8%

Selling and marketing expenses

53,215

39,272

146,273

108,335

General, administrative and other expenses

29,385

24,761

83,037

68,847

Operating income

68,154

42,676

59.7%

174,294

97,719

78.4%

Other expense, net:

Interest expense, net

(4,068)

(4,311)

(11,043)

(13,359)

Other (expense) income, net

(624)

(214)

(525)

404

Total other expense

(4,692)

(4,525)

(11,568)

(12,955)

Income before income taxes

63,462

38,151

66.3%

162,726

84,764

92.0%

Income tax provision

19,324

12,467

51,830

28,885

   Net income

$

44,138

$

25,684

$

110,896

$

55,879

        Net loss (income) attributable to                                         the noncontrolling interest

60

-

(44)

-

   Net income attributable to common stockholders

$

     44,198

$

25,684

72.1%

$

110,852

$

55,879

98.4%

Earnings per common share:

Basic

$

0.64

$

0.34

$

1.56

$

0.75

Diluted

$

0.62

$

0.34

$

1.51

$

0.74

Weighted average common shares outstanding:

Basic

69,199

74,938

71,065

74,902

Diluted

71,433

76,166

73,450

75,396

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands)

September 30,

December 31,

2010

2009

ASSETS

Current Assets:

    Cash and cash equivalents

$

38,048

$

14,042

    Accounts receivable, net

127,453

105,576

    Inventories

68,175

57,686

    Prepaid expenses and other current assets

15,027

11,268

    Deferred income taxes

19,155

20,411

Total Current Assets

267,858

208,983

    Property, plant and equipment, net

162,910

172,497

    Goodwill

211,723

193,391

    Other intangible assets, net

69,179

64,717

    Other non-current assets

4,280

3,791

Total Assets

$

715,950

$

643,379

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities:

    Accounts payable

$

62,798

$

47,761

    Accrued expenses and other current liabilities

94,461

81,452

    Income taxes payable

19,846

7,312

Total Current Liabilities

177,105

136,525

    Long-term debt

436,000

297,470

    Deferred income taxes

30,732

29,865

    Other non-current liabilities

4,254

7,226

Total Liabilities

648,091

471,086

Equity attributable to common stockholders

66,590

172,293

Equity attributable to the noncontrolling interest

1,269

Total Stockholders' Equity

67,859

172,293

Total Liabilities and Stockholders' Equity

$

715,950

$

643,379

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

Nine Months Ended

September 30,

2010

2009

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income

$

110,896

$

55,879

Adjustments to reconcile net income to net cash provided by operating activities:

       Depreciation and amortization

23,870

23,526

       Amortization of stock-based compensation

7,953

6,448

       Amortization of deferred financing costs

517

518

       Bad debt expense

2,072

4,659

       Deferred income taxes

(1,509)

(8,006)

       Foreign currency adjustments

(1,504)

34

Loss on disposal of equipment

1,081

Changes in operating assets and liabilities, net of effects of acquired business

(3,662)

37,345

Net cash provided by operating activities

139,714

120,403

CASH FLOWS FROM INVESTING ACTIVITIES:

Acquisition of business, net of cash acquired

(18,692)

Purchases of property, plant and equipment

(12,330)

(8,961)

Payments for other

(152)

(87)

Net cash used by investing activities

(31,174)

(9,048)

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from long-term revolving credit facility

289,336

85,797

Repayments of long-term revolving credit facility

(149,313)

(189,036)

Proceeds from issuance of common stock

22,015

129

Excess tax benefit from stock-based compensation

3,282

Treasury shares repurchased

(250,000)

Net cash used by financing activities

(84,680)

(103,110)

NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

146

(3,627)

Increase in cash and cash equivalents

24,006

4,618

CASH AND CASH EQUIVALENTS, beginning of period

14,042

15,385

CASH AND CASH EQUIVALENTS, end of period

$

38,048

$

20,003

Summary of Channel Sales

The Company generates sales through four distribution channels: retail, direct, healthcare and third party.  The retail channel sells to furniture, specialty and department stores globally.  The direct channel sells directly to consumers.  The healthcare channel sells to hospitals, nursing homes, healthcare professionals and medical retailers.  The third party channel sells to distributors in countries where Tempur-Pedic International does not operate its own distribution company.

On April 1, 2010, the Company purchased its third party distributor in Canada. Accordingly, net sales in the Canadian market are reported in the appropriate channels within the North American segment. As Canada represented essentially all sales through the North American third party channel, the Company no longer reports third party sales in this segment.

The following table highlights net sales information, by channel and by segment:

(In thousands)

CONSOLIDATED

NORTH AMERICA

INTERNATIONAL

Three Months Ended

Three Months Ended

Three Months Ended

September 30,

September 30,

September 30,

2010

2009

2010

2009

2010

2009

Retail

$

261,425

$

191,012

$

197,586

$

129,883

$

63,839

$

61,129

Direct

17,072

12,245

14,192

10,600

2,880

1,645

Healthcare

8,158

8,942

2,909

2,804

5,249

6,138

Third Party

9,130

11,883

-

2,990

9,130

8,893

$

295,785

$

224,082

$

214,687

$

146,277

$

81,098

$

77,805

Summary of Product Sales

The following table highlights net sales information, by product and by segment:

(In thousands)

CONSOLIDATED

NORTH AMERICA

INTERNATIONAL

Three Months Ended

Three Months Ended

Three Months Ended

September 30,

September 30,

September 30,

2010

2009

2010

2009

2010

2009

Mattresses

$

199,168

$

149,810

$

150,941

$

103,122

$

48,227

$

46,688

Pillows

33,961

28,386

18,307

13,216

15,654

15,170

Other

62,656

45,886

45,439

29,939

17,217

15,947

$

295,785

$

224,082

$

214,687

$

146,277

$

81,098

$

77,805

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

Reconciliation of Adjusted EBITDA to Net Income and Funded debt to Total debt

Non-GAAP Measures

(In thousands)

The Company provides information regarding Adjusted EBITDA and Funded debt which are not recognized terms under U.S. GAAP (Generally Accepted Accounting Principles) and do not purport to be alternatives to Net income as a measure of operating performance or Total debt. A reconciliation of Adjusted EBITDA to the Company's Net income and a reconciliation of Funded debt to Total debt are provided below. Management believes that the use of Adjusted EBITDA and Funded debt provides investors with useful information with respect to the terms of the Company's credit facility.

Reconciliation of Net income to Adjusted EBITDA

The following table sets forth the reconciliation of the Company's reported Net income to the calculation of Adjusted EBITDA for each of the three months ended December 31, 2009, March 31, 2010, June 30, 2010 and September 30, 2010, as well as the twelve months ended September 30, 2010:

Three Months Ended

Twelve Months Ended

December 31, 2009

March 31, 2010

June 30, 2010

September 30, 2010

September 30, 2010

GAAP Net income attributable to common stockholders

$

            29,114

$         33,148

$    33,506

$    44,198

$           139,966

Plus:

  Interest expense

3,990

3,189

3,786

4,068

15,033

  Income taxes

14,159

16,021

16,485

19,324

65,989

  Depreciation  &  

  Amortization

10,239

9,996

11,049

10,778

42,062

  Other (1)

-

361

202

-

563

Adjusted EBITDA

$

           57,502

$         62,715

$    65,028

$    78,368

263,613

(1) Includes professional costs incurred in connection with the acquisition of the Company's Canadian distributor, which closed on April 1, 2010. In accordance with the Company's credit facility, this amount is excluded from the calculation of Adjusted EBITDA for purposes of calculating compliance with the ratio of Funded debt to Adjusted EBITDA.

Reconciliation of Funded debt to Total debt

The following table sets forth the reconciliation of the Company's reported Total debt to the calculation of Funded debt as of September 30, 2010:

As of

September 30, 2010

GAAP basis Total debt

$

436,000

Plus:

  Letters of credit outstanding

13,106

Funded debt

$

449,106

Calculation of Funded debt to Adjusted EBITDA

As of

September 30, 2010

Funded debt

$

449,106

Adjusted EBITDA

263,613

1.70 times

SOURCE Tempur-Pedic International Inc.



RELATED LINKS

http://www.tempurpedic.com